JAK-STAT Signaling

Handbook of Cell Signaling: Volume 1-3

Volumn 1-3, Issue , 2003, Pages 343-348

  Bhandari, Rashna ^a,b,c   Kuriyan, John ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 58149085661     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012124546-7/50422-8     Document Type: Chapter

References (46)

1. J.J.E. Darnell, et al. (1994) JAK-STAT pathways and transcriptional activation in response to IFNs and other and other extracellular signaling proteins. Science 264 1415-1421.
2. J.N. Ihle, et al. (1995) Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol. 13 369-398.
3. J.N. Ihle, et al. (1994) Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem. Sci. 19 222-227.
4. S. Pellegrini and I. Dusanter-Fourt (1997) The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs). Eur. J. Biochem. 248 615-633.
5. J.F. Bazan (1990) Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA 87 6934-6938.
6. E. Thoreau, et al. (1991) Structural symmetry of the extracellular domain of the cytokine/growth hormone/prolactin receptor family and interferon receptors revealed by hydrophobic cluster analysis. FEBS Lett. 282 26-31.
7. S.V. Kotenko and S. Pestka (2000) JAK-STAT signal transduction pathway through the eyes of cytokine class II receptor complexes. Oncogene 19 2557-2565.
8. T. Taga and T. Kishimoto (1995) Signaling mechanisms through cytokine receptors that share signal transducing receptor components. Curr. Opin. Immunol. 7 17-23.
9. M. Murakami, et al. (1991) Critical cytoplasmic region of the interleukin 6 signal transducer gp 130 is conserved in the cytokine receptor family. Proc. Natl. Acad. Sci. USA 88 11349-11353.
10. J. Feng, et al. (1997) Activation of JAK2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop. Mol. Cell. Biol. 17 2497-2501.
11. O. Livnah, et al. (1999) Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 283 987-990.
12. R.S. Syed, et al. (1998) Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature 395 511-516.
13. I. Remy, I.A. Wilson and S.W. Michnick (1999) Erythropoietin receptor activation by a ligand-induced conformation change. Science 283 990-993.
14. I.A. Wilson and L.K. Jolliffe (1999) The structure, organization, activation and plasticity of the erythropoietin receptor. Curr. Opin. Struct. Biol. 9 696-704.
15. J.A. Girault, et al. (1999) The N-termini of FAK and JAKs contain divergent band 4.1 domains. Trends Biochem. Sci. 24 54-57.
16. A.H. Chishti, et al. (1998) The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem. Sci. 23 281-282.
17. C.M. Hilkens, et al. (2001) A region encompassing the FERM domain of JAK1 is necessary for binding to the cytokine receptor gp130. FEBS Lett. 505 87-91.
18. Y.J. Zhou, et al. (2001) Unexpected effects of FERM domain mutations on catalytic activity of Jak3: structural implication for Janus kinases. Mol. Cell. 8 959-969.
19. K. Hamada, et al. (2000) Structural basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain. EMBO J. 19 4449-4462.
20. M.A. Pearson, et al. (2000) Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain. Cell 101 259-270.
21. D. Kampa and J. Burnside (2000) Computational and functional analysis of the putative SH2 domain in Janus kinases. Biochem. Biophys. Res. Commun. 278 175-182.
22. B. Al-Lazikani, et al. (2001) Combining multiple structure and sequence alignments to improve sequence detection and alignment: application to the SH2 domains of Janus kinases. Proc. Natl. Acad. Sci. USA 98 14796-14801.
23. D.A. Harrison, et al. (1995) Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects. EMBO J. 14 2857-2865.
24. M. Chen, et al. (2000) Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: evidence for interactions between the kinase and pseudokinase domains. Mol. Cell. Biol. 20 947-956.
25. H. Luo, et al. (1997) Mutation in the JAK kinase JH2 domain hyperactivates Drosophila and mammalian JAK-STAT pathways. Mol. Cell. Biol. 17 1562-1571.
26. J.E. Darnell Jr. (1997) STATs and gene regulation. Science 277 1630-1635.
27. X. Chen, et al. (1998) Crystal structure of a tyrosine-phosphorylated STAT-1 dimer bound to DNA. Cell 93 827-839.
28. S. Becker, B. Groner and C.W. Müller (1998) Three-dimensional structure of the STAT3β homodimer bound to DNA. Nature 394 145-151.
29. K. Shuai, et al. (1993) Polypeptide signalling to the nucleus through tyrosine phosphorylation of JAK and STAT proteins. Nature 366 580-583.
30. K. Shuai, et al. (1994) Interferon activation of the transcription factor STAT91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell 76 821-828.
31. X. Xu, Y.L. Sun and T. Hoey (1996) Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science 273 794-797.
32. U. Vinkemeier, et al. (1996) DNA binding of in vitro activated STAT1α, STAT1b, and truncated STAT1: interaction between NH2-terminal domains stabilizes binding of two dimers to tandem DNA sites. EMBO J. 15 5616-5626.
33. S. John, et al. (1999) The significance of tetramerization in promoter recruitment by Stat5. Mol. Cell. Biol. 19 1910-1918.
34. D. Thanos and T. Maniatis (1995) Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 83 1091-1100.
35. C.J. Greenhalgh and D.J. Hilton (2001) Negative regulation of cytokine signaling. J. Leukoc. Biol. 70 348-356.
36. U. Klingmuller, et al. (1995) Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80 729-738.
37. H. Jiao, et al. (1996) Direct association with and dephosphorylation of JAK2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1. Mol. Cell. Biol. 16 6985-6992.
38. R. Starr and D.J. Hilton (1999) Negative regulation of the JAK/STAT pathway. Bioessays 21 47-52.
39. D.J. Hilton, et al. (1998) Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. USA 95 114-119.
40. R. Starr, et al. (1997) A family of cytokine-inducible inhibitors of signalling. Nature 387 917-921.
41. T.A. Endo, et al. (1997) A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387 921-924.
42. T. Naka, et al. (1997) Structure and function of a new STAT-induced STAT inhibitor. Nature 387 924-929.
43. A. Yoshimura, et al. (1995) A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J. 14 2816-2826.
44. J.G. Zhang, et al. (1999) The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc. Natl. Acad. Sci. USA 96 2071-2076.
45. B. Liu, et al. (1998) Inhibition of STAT1-mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. USA 95 10626-10631.
46. I.P. Touw, et al. (2000) Signaling mechanisms of cytokine receptors and their perturbances in disease. Mol. Cell. Endocrinol. 160 1-9.